Related Experiment Video
Updated: Aug 9, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Published on: February 22, 2019
Risk Factors of Exchange Blood Transfusion in Infants With Severe Pertussis
Tingting Shi1, Shuling Du2, Huifeng Fan1
1Department of Respiration, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China.
Insights
Exchange blood transfusion (ET) can improve outcomes for severe pertussis patients. This therapy is recommended for infants with high fever, elevated C-reactive protein (CRP), and high white blood cell (WBC) counts.
Area of Science:
- Pediatrics
- Infectious Diseases
- Critical Care Medicine
Background:
- Severe pertussis can lead to life-threatening complications.
- Intensive therapeutic measures may not always be sufficient for severe pertussis cases.
Purpose of the Study:
- To assess the effectiveness of exchange blood transfusion (ET) in severe pertussis.
- To identify risk factors associated with the need for ET in infants with severe pertussis.
Main Methods:
- Retrospective analysis of medical records of 12 severe pertussis patients requiring ET.
- Statistical analysis to determine independent risk factors for ET.
Main Results:
- Eight out of 12 patients (66.7%) survived after ET.
- Independent risk factors for ET included temperature ≥ 38.5°C, C-reactive protein (CRP) >30 mg/L, and white blood cell (WBC) count > 40.0 × 10^9/L.
- ET demonstrated effectiveness in improving outcomes for severe pertussis.
Conclusions:
- Exchange blood transfusion is a potentially effective therapy for severe pertussis.
- Consider ET for severe pertussis patients presenting with high fever, elevated CRP, and high WBC counts.
Abstract:
Exchange blood transfusion (ET) reportedly improves the outcomes of the patients with severe pertussis accompanied with deadly complications continued to worsen despite intensive therapeutic measures. This study assessed the medical records of 12 patients with severe pertussis requiring ET therapy who were admitted to our medical center. Of the 12 patients requiring ET therapy, 8 survived and 4 died. The independent risk factors for requiring ET therapy in infants with severe pertussis were T ≥ 38.5°C (odds ratio [OR], 11.697; 95% confidence interval [CI], 1.325-262.184; P = .046), C-reactive protein (CRP) >30 mg/L (OR, 62.393; 95% CI, 6.264-2381.773; P = .004), and WBC > 40.0 × 109/L (OR, 68.509; 95% CI, 8.118-1829.695; P = .001). ET therapy worked effectively for our severe pertussis cases. When the severe pertussis patients with T ≥ 38.5°C, CRP >30 mg/L, and WBC > 40.0 × 109/L, ET therapy might be taken into consideration.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Rh Blood Group
Pulmonary Cycle: Exhalation